Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Cephalon |
---|---|
Information provided by: | Cephalon |
ClinicalTrials.gov Identifier: | NCT00242827 |
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
Condition | Intervention | Phase |
---|---|---|
Myeloma |
Drug: Oral CEP-701 |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Crossover Assignment, Safety/Efficacy Study |
Official Title: | An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients are included in the study if all of the following criteria are met:
Exclusion Criteria:
Patients are excluded from participating in this study if 1 or more of the following criteria are met:
United States, Georgia | |
Emory University Winship Cancer Institute | |
Atlanta, Georgia, United States, 30302 | |
United States, Indiana | |
Indiana Univeristy Cancer Research Center | |
Indianapolis, Indiana, United States, 46202 | |
United States, New Jersey | |
The Cancer Center Hackensack University Medical Center | |
Hackensack, New Jersey, United States, 07601 | |
United States, New York | |
New York Presbyterian Hospital | |
New York, New York, United States, 10021 | |
United States, Pennsylvania | |
Abramson Cancer Center Of University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 |
Study Director: | Peter Brown | Cephalon |
Study ID Numbers: | C0701/2025/ON/US |
Study First Received: | September 27, 2005 |
Last Updated: | September 5, 2006 |
ClinicalTrials.gov Identifier: | NCT00242827 |
Health Authority: | United States: Food and Drug Administration |
Immunoproliferative Disorders Hemorrhagic Disorders Multiple myeloma Hematologic Diseases Blood Protein Disorders Blood Coagulation Disorders |
Vascular Diseases Paraproteinemias Lymphoproliferative Disorders Hemostatic Disorders Neoplasms, Plasma Cell Multiple Myeloma |
Neoplasms Neoplasms by Histologic Type Immune System Diseases Cardiovascular Diseases |